AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on November 17, 2026

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent
Influential Women: Gabriela Torres, Connects Government, Startups, & People to Advance Responsible AI in Massachusetts$
Value Network IPA Selects Dimensional Insight to Unify Behavioral Health Data Across Western New York
EPC Space and Mouser Electronics Announce Global Distribution Agreement
Alexander Hughes Shares Boston Life Sciences Hiring Insights
Influential Women: Jennifer Toomey, Bringing Science-Driven Innovation and Team Leadership to Natural Supplements
UUUU: Energy Fuels Investors Encouraged to Contact Block & Leviton to Possibly Recover Losses
ABX INVESTIGATION: Abacus Global Management Investigated for Securities Fraud by Block & Leviton; Contact the Firm to Possibly Recover Losses
Crestwood Advisors Names Aaron S. Dunn, CFA, Chief Investment Officer
Historic Forest Theater and True Tickets Announce Partnership, Bringing a More Connected, Mobile-First Ticketing Experience to the Newly Reopened South Dallas Landmark
Stop & Shop Delivers Thanksgiving to Thousands of Families Through Annual Turkey Express Program
Payscale launches JobNav to bring governance to the jobs that drive every pay decision
Nift Surpasses $1 Billion in Gift Value, Adds Senior Leaders from Block, CVS Health and Taboola to Scale North America and EMEA
Rocket Software Introduces Rocket® Transaction Platform to Make Mission-Critical Applications More Agile and AI-ready
ConnectM Reports 9% Revenue Growth to $8.9 Million, 139% Growth in Core Businesses and 28% Improvement in Operating Loss for Third Quarter 2026
Generative AI can empower entrepreneurs, but also entrap them
Mobile Apps for DNA Sequencing Market to Reach $2.4 Billion by 2031
Zenas BioPharma Launches The Distance Between Platform to Bring Greater Visibility to the Hidden Burden of IgG4-Related Disease
Destination XL Group Files Definitive Proxy Statement and Mails Letter to Stockholders

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.